Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Change in Receivables (2019 - 2025)

Outset Medical (OM) has disclosed Change in Receivables for 7 consecutive years, with -$1.8 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 192.08% to -$1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.8 million through Dec 2025, down 175.32% year-over-year, with the annual reading at -$3.8 million for FY2025, 175.32% down from the prior year.
  • Change in Receivables for Q4 2025 was -$1.8 million at Outset Medical, up from -$2.9 million in the prior quarter.
  • The five-year high for Change in Receivables was $6.3 million in Q4 2021, with the low at -$2.9 million in Q3 2025.
  • Average Change in Receivables over 5 years is $1.4 million, with a median of $1.4 million recorded in 2022.
  • The sharpest move saw Change in Receivables surged 1510.73% in 2021, then tumbled 2186.33% in 2025.
  • Over 5 years, Change in Receivables stood at $6.3 million in 2021, then dropped by 11.34% to $5.6 million in 2022, then tumbled by 144.23% to -$2.5 million in 2023, then surged by 177.73% to $1.9 million in 2024, then tumbled by 192.08% to -$1.8 million in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$1.8 million, -$2.9 million, and -$574000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.